ArticleNature cancer2020

An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia.

Jeevisha Bajaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.